Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing